Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: A comparative clinical analysis

Keyphrases

• Acute Myeloid Leukemia 100%
• High Dose 100%
• Myelodysplastic Syndrome 100%
• Reduced Intensity 100%
• Allotransplantation 100%
• Trial Sequential Analysis 100%
• Myeloablative 50%
• Graft-versus-host Disease (GvHD) 33%
• Allograft 33%
• Hematopoietic Stem Cell Transplantation 33%
• Disease-free Survival 33%
• Patient Median 33%
• Disease Management 16%
• Older Patients 16%
• Reduced-intensity Conditioning 16%
• Myeloablative Conditioning 16%
• Young Patients 16%
• Overall Survival 16%
• Graft Failure 16%
• Disease-specific Mortality 16%
• Neutrophil Engraftment 16%
• Relapsed Disease 16%
• Treatment-related Mortality 16%
• Host Treatment 16%
• Pre-existing Comorbidity 16%
• Platelet Recovery 16%

Medicine and Dentistry

• Drug Megadose 100%
• Allograft 100%
• Acute Myeloid Leukemia 100%
• Myelodysplastic Syndrome 100%
• Hematopoietic Stem Cell Transplantation 66%
• Disease Free Survival 66%
• Graft Versus Host Reaction 66%
• Disease Management 33%
• Engraftment 33%
• Platelet 33%
• Graft Failure 33%
• Myeloablative Conditioning 33%
• Reduced Intensity Conditioning 33%
• Overall Survival 33%
• Comorbidity 33%
• Diseases 33%
• Neutrophil 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Graft Versus Host Reaction 100%
• Disease Free Survival 100%
• Myelodysplastic Syndrome 100%
• Acute Myeloid Leukemia 100%
• Overall Survival 50%
• Graft Failure 50%
• Comorbidity 50%
• Diseases 50%